The United States

George Clinical in The United States

Twitter

Facebook

Linkedin

George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialised oncology CRO Division

Headquartered in Sydney, Australia, George Clinical has offices in China, India, Hong Kong, South Korea, Taiwan, Malaysia, New Zealand, United Kingdom, Czech Republic and now the USA.

Over the years, George Clinical has grown rapidly across the Asia-Pacific region and is continuing to develop global operations. The combination of a strong commercial proficiency and clinical research and scientific excellence positions George Clinical as a high quality, global CRO with substantial clinical and scientific assets.

George Clinical now has substantial operations in the USA, with 42 staff and leaders in oncology trials both operationally and scientifically. We are here to support our US customers with their CRO needs and to lead oncology trials across our core operational facilities in the Asia Pacific region.

George Clinical US Staff Locations

George Clinical US News

George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialised oncology CRO Division

George Clinical, a leading full-service CRO in the Asia-Pacific region and Vector Oncology, a Memphis-based leader in oncology research and data analytics, formally announced today that George Clinical has acquired Vector Oncology’s Pharma Services (CRO) Division…

Experts from China and Australia Congregate in Qingdao to Promote SSaSS Study

On September 19 2018, the ‘Salt Substitute and Stroke Study (SSaSS) Annual Meeting 2018’ was held in Qingdao. Over 50 participants joined the meeting to review progress on the study and exchange experiences. Those who attended the meeting included Principal Inve...

The 2018 Design and Statistical Analysis of Clinical Studies Training Program was successfully held

The 2018 Design and Statistical Analysis of Clinical Studies Training Program, organized by the Heart Health Research Center (hereafter abbreviated as HHRC), was successfully held in Beijing on September 17 2018. Over 40 doctors, trainees and medical practitioners, ...

Research reveals link between high blood pressure and risk of aortic valve disease

New research has found that long-term exposure to high blood pressure is associated with an increased risk of aortic valve disease, with significant implications for clinical practice guidelines and health management.

Rates of Sepsis have been hugely underestimated, according to a new study

The number of people with sepsis in Australian intensive care units (ICUs) is 50% higher than previously reported. The report from Royal North Shore Hospital and The George Institute for Global Health also found death rates for sepsis had been underestimated by ...

Publicly funded dialysis programs represent a good beginning but need to address poor survival and high drop-out rates, reveals a new study

Making provision for free treatment under a publicly funded dialysis program allows more people with advanced kidney failure to access this expensive treatment but is not able to address all barriers to ensure long-term success, reveals a new study by The George...

Global Research Recognition for The George Institute

The George Institute for Global Health has been ranked the top independent research organisation in Australia, and come in at 33rd overall in the world.

Details